Leading Cell Therapy & Cord Blood Banking
The Cell Therapy Unit and Cord Blood Bank at Mardaleishvili Medical Centre is a dedicated center for advanced cellular technologies, combining stem cell banking, laboratory processing, and clinical applications within a single multidisciplinary infrastructure. The department supports both established medical treatments and the ongoing development of regenerative medicine, providing patients and families with access to state-of-the-art cell preservation and therapeutic expertise.
At the heart of the department is GeoCord, one of the first private cord blood banks in the South Caucasus. Established in 2006, GeoCord was created to preserve the unique therapeutic potential of newborn stem cells through advanced cryopreservation technologies and rigorous laboratory protocols. Since its inception, the bank has continuously expanded its scientific capabilities while adhering to internationally recognized quality standards.
Today, the department extends far beyond cord blood storage. Its laboratories and clinical specialists work together in the fields of stem cell processing, bone marrow cell technologies, immunotherapy, and regenerative medicine, creating an integrated environment where research, laboratory science, and patient care support one another. This combination of clinical expertise and modern biotechnology enables the Centre to provide comprehensive cellular medicine solutions while contributing to the future of personalized healthcare.
At a Glance
Founded: 2006
Commercial operations since 2007
ISO 9001 Certified
Advanced Cryopreservation Laboratory
Worldwide Sample Transportation
Integrated Cell Therapy Center
State-of-the-Art Processing & Long-Term Storage
The quality of a stem cell sample depends not only on its collection but also on every stage that follows. At the Cell Therapy Unit and Cord Blood Bank, each sample undergoes a strictly controlled, multi-stage workflow designed to preserve maximum cell viability, ensure biological safety, and maintain long-term therapeutic potential.
Immediately after collection, cord blood is transported to the laboratory under controlled temperature conditions and processed without delay. Upon arrival, the sample is registered, uniquely coded, and entered into a secure tracking system, ensuring full traceability throughout its entire lifecycle.
The processing procedure includes several standardized stages:
- Initial registration and identification of the sample in the laboratory database
- Volume reduction and plasma separation to concentrate stem cells
- Isolation of nucleated (stem) cells using validated laboratory methods
- Comprehensive quality control testing, including sterility assessment, cell count, and viability evaluation
- Preparation of the final stem cell concentrate for cryogenic storage
Only samples that fully meet strict laboratory criteria proceed to the next stage of preservation.
Cryopreservation is performed using programmable controlled-rate freezing technology, which ensures gradual and controlled cooling of the cells. This minimizes intracellular ice formation and protects cellular structures. After freezing, samples are transferred into liquid nitrogen storage at temperatures below –196°C, where biological activity is effectively suspended, allowing long-term preservation for decades.
The storage system is designed with multiple layers of safety and monitoring:
- Continuous temperature monitoring systems
- Redundant backup power supply
- Secure cryogenic storage tanks with controlled access
- Regular technical and biological quality audits
- Full documentation and traceability for every stored unit
By combining advanced laboratory processing, strict quality control, and highly secure cryogenic storage infrastructure, the Cell Therapy Unit ensures that each preserved sample maintains its integrity and remains available for potential future medical use when clinically indicated.
Supporting Personalized Regenerative Medicine
Stem cell banking is an investment in future medical possibilities. As regenerative medicine continues to evolve, preserved newborn stem cells may become an important resource for emerging therapies aimed at repairing damaged tissues, restoring biological function, and supporting personalized treatment strategies.
As part of Mardaleishvili Medical Centre, the Cord Blood Bank operates alongside a specialized Cell Therapy Unit actively engaged in advanced cellular technologies. The Centre’s expertise includes stem cell processing, bone marrow cell technologies, dendritic cell vaccines, LAK immunotherapy, and other innovative approaches that combine laboratory science with clinical practice.
This close integration between biobanking, cell processing, and clinical application creates a unique multidisciplinary environment where research and patient care continuously support one another. While cord blood is currently used in established treatments for a range of hematological and immune disorders, ongoing scientific advances continue to expand the potential role of stem cells in regenerative medicine. Future applications remain an active area of research and depend on clinical evidence and regulatory approval.
By preserving newborn stem cells today, families gain access to a valuable biological resource while benefiting from the expertise of a medical center committed to advancing the future of personalized healthcare through innovation, scientific research, and responsible clinical practice.
To learn more or to discuss cord blood banking options for your family, please fill out the contact form and our specialists will get in touch with you.
Get In Touch With Us
For general questions, please send us a message and we’ll get right back to you. You can also call us directly to speak with a member of our service team or insurance expert.
Fields marked with a * are required.
